Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
Go back to Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024| (NASDAQ: VRDN) | Delayed: 22.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.92 | 52 Week High | $ | |||
| Open | $22.92 | 52 Week Low | $ | |||
| Day High | $22.92 | P/E | N/A | |||
| Day Low | $22.92 | EPS | $ | |||
| Volume | 12,623 | |||||

